Pharming PHAR
NASDAQ PHAR
$13.40 +0.38 (+2.95%)
As of: Nov 11, 2026 · 12:32 PM EST

Pharming (PHAR) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Pharming (PHAR) posted Return on Capital Employed [ROCE] of -2.22% for Q3 2026, down 1.36 percentage points from -0.86% a year earlier and down 0.02 percentage points from the prior quarter.

Analysis

Pharming (PHAR) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Pharming's Return on Capital Employed [ROCE] came in at 7.73%, up 12.01 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -21.56 percentage points (FY2020 to FY2025).
  • In prior years, Pharming's Return on Capital Employed [ROCE] was -4.28% in FY2024 (-2.81 pp), -1.47% in FY2023 (-9.54 pp), 8.07% in FY2022 (+3.31 pp) and 4.76% in FY2021 (-24.53 pp).
  • The Q3 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] since Q1 2025.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in four of the last eight quarters, with an average year-over-year change of +2.18 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2022, with a gain of 12.70 percentage points; the weakest was Q3 2023, with a drop of 26.73 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -2.20% (Q2 2026), -0.29% (Q1 2026) and -0.86% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Pharming 927.62 Mn 229.29 Mn 102.20 -2.23%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -2.23%
Jun 30, 2026 -2.21%
Mar 31, 2026 -0.29%
Dec 31, 2025 -0.87%
Sep 30, 2025 -0.87%
Jun 30, 2025 0.26%
Mar 31, 2025 -6.91%
Dec 31, 2024 -9.34%
Sep 30, 2024 -8.96%
Jun 30, 2024 -9.38%
Mar 31, 2024 -3.27%
Dec 31, 2023 -1.44%
Sep 30, 2023 -4.56%
Jun 30, 2023 -2.98%
Mar 31, 2023 0.48%
Dec 31, 2022 11.87%
Sep 30, 2022 22.17%
Jun 30, 2022 9.94%
Mar 31, 2022 7.79%
Dec 31, 2021 8.73%
API Access

Pharming Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PHAR&period=max&api_key=YOUR_API_KEY